Fig. 5From: Interleukin-24-mediated antitumor effects against human glioblastoma via upregulation of P38 MAPK and endogenous TRAIL-induced apoptosis and LC3-II activation-dependent autophagyAd/IL-24 inhibited glioblastoma cells growth in vitro by inducing cell cycle arrest. A-F: by flow cytometry, U87 cells treated with Ad/IL-24 or Ad/GFP were harvested after 48 h and stained with PI. F: Cell cycle distribution was analyzed by flow cytometry and the percentage of cell-cycle phases was analyzed by Flow Jo Software. Each bar represents the mean ±SD of five independent experiments. *(P<0.364), **(P<0.0027), ***(P<0.001), ****(P <0.0001)Back to article page